Eucrates Biomedical Acquisition Corp. carries a market capitalization of 47.26M, placing it among publicly traded companies globally.
| Market Cap | 47.26M |
| Enterprise Value | N/A |
Eucrates Biomedical Acquisition Corp.'s stock has gained approximately 1.00806% over the past 52 weeks. The 50-day moving average sits at 10.29, while the 200-day moving average is 10.07.
| Beta (5Y) | N/A |
| 52-Week Price Change | 1.00806% |
| 50-Day Moving Average | 10.29 |
| 200-Day Moving Average | 10.07 |
| Average Volume (20 Days) | N/A |